ERBB2 and congestive heart failure: Trastuzumab, an antibody targeting the Human epidermal growth factor receptor 2 (HER2), Trastuzumab may trigger an asymptomatic decreased in LV ejection fraction, or in some cases, congestive heart failure [385].